Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 501–600 of 1,009
Ligand-Dependent Exponential Amplification of a Self-Replicating l -RNA Enzyme
Olea, C., Horning, D. P., & Joyce, G. F. (2012) · Journal of the American Chemical Society · doi:10.1021/ja302197x · Cited by 38
DNase-Mediated Single-Cycle Selection of Aptamers for Proteins Blotted on a Membrane
Liu, Y., Wang, C., Li, F., Shen, S., Tyrrell, D. L., Le, X. C., & Li, X. (2012) · Analytical Chemistry · doi:10.1021/ac302047e · Cited by 39
Aptamers as Valuable Molecular Tools in Neurosciences
Wolter, O., & Mayer, G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1969-16.2017 · Cited by 47
Mueller, S. K., Nocera, A. L., Dillon, S. T., Wu, D., Libermann, T. A., & Bleier, B. S. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22189 · Cited by 42
Affinity Interactions by Capillary Electrophoresis: Binding, Separation, and Detection
Yu, F., Zhao, Q., Zhang, D., Yuan, Z., & Wang, H. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04741 · Cited by 42
Thevendran, R., Sarah, S., Tang, T., & Citartan, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.051 · Cited by 40
Ghaemi, M. S., Tarca, A. L., Romero, R. J., Stanley, N., Fallahzadeh, R., Tanada, A., Culos, A., Ando, K., Han, X., Blumenfeld, Y. J., et al. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1888915 · Cited by 41
Dom, Z. I. M., Satake, E., SKUPIEN, J. K., Krolewski, B., O’Neil, K. V., Willency, J. A., Dillon, S. T., Wilson, J. M., Kobayashi, H. H., Ihara, K., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2699 · Cited by 42
Evolution of Functionally Enhanced α- l -Threofuranosyl Nucleic Acid Aptamers
McCloskey, C. M., Li, Q., Yik, E. J., Chim, N., Ngor, A. K., Medina, E. L., Grubisic, I., Keh, L. C. T., Poplin, R. E., & Chaput, J. C. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00481 · Cited by 42
Nocera, A. L., Mueller, S. K., Workman, A. D., Wu, D., McDonnell, K., Sadow, P. M., Amiji, M. M., & Bleier, B. S. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.04.034 · Cited by 44
Flow-Cell-Based Technology for Massively Parallel Characterization of Base-Modified DNA Aptamers
Wu, D., Feagin, T., Mage, P. L., Rangel, A. E., Wan, L., Kong, D., Li, A., Coller, J., Eisenstein, M. S., & Soh, H. T. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04777 · Cited by 38
Aptamers: new arrows to target dendritic cells
Ganji, A., Varasteh, A., & Sankian, M. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1041962 · Cited by 38
Saito, S., Hirose, K., Tsuchida, M., Wakui, K., Yoshimoto, K., Nishiyama, Y., & Shibukawa, M. (2015) · Chemical Communications · doi:10.1039/c5cc07268a · Cited by 45
Enzyme-Linked Aptamer Assay (ELAA) for Detection of Toxoplasma ROP18 Protein in Human Serum
Vargas-Montes, M., Cardona, N., Giraldo, D. M., Molina, D. A., Zhang, Y., & Gómez‐Marín, J. E. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00386 · Cited by 38
Cuvelliez, M., Vandewalle, V., Brunin, M., Beseme, O., Hulot, A., de Groote, P., Amouyel, P., Bauters, C., Marot, G., & Pinet, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-55727-1 · Cited by 41
Circulating testican-2 is a podocyte-derived marker of kidney health
Ngo, D., Wen, D., Gao, Y. L., Keyes, M. J., Drury, E. R., Katz, D. H., Benson, M. D., Sinha, S., Shen, D., Farrell, L. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009606117 · Cited by 39
Emerging biosensing platforms for quantitative detection of exosomes as diagnostic biomarkers
Tan, J., Wen, Y., & Li, M. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214111 · Cited by 42
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction
Zhang, L., Cunningham, J. W., Claggett, B. L., Jacob, J., Mendelson, M., Serrano‐Fernández, P., Kaiser, S., Yates, D. P., Healey, M. L., Chen, C., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.061481 · Cited by 41
In Vitro Selection Using Modified or Unnatural Nucleotides
Stovall, G. M., Bedenbaugh, R. S., Singh, S., Meyer, A. J., Hatala, P. J., Ellington, A. D., & Hall, B. (2014) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0906s56 · Cited by 38
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
Pena, M. J., Mischak, H., & Heerspink, H. J. L. (2016) · Diabetologia · doi:10.1007/s00125-016-4001-9 · Cited by 89
Than, N. G., Romero, R. J., Györffy, D., Posta, M., Bhatti, G., Done, B., Chaemsaithong, P., Jung, E., Suksai, M., Gotsch, F., et al. (2022) · Journal of Perinatal Medicine · doi:10.1515/jpm-2022-0433 · Cited by 38
An aptamer-based depot system for sustained release of small molecule therapeutics
Wang, D., Li, Y., Deng, X., Torre, M., Zhang, Z., Li, X., Zhang, W., Cullion, K., Kohane, D. S., & Weldon, C. B. (2023) · Nature Communications · doi:10.1038/s41467-023-37002-0 · Cited by 37
A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Halama, A., Zaghlool, S. B., Thareja, G., Kader, S. A., Al‐Muftah, W., Mook-Kanamori, M. J., Sarwath, H., Mohamoud, Y. A., Stephan, N., Ameling, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51134-x · Cited by 46
Baumstummler, A., Lehmann, D., Janjić, N., & Ochsner, U. A. (2014) · Letters in Applied Microbiology · doi:10.1111/lam.12295 · Cited by 37
Self-citationFunctional nucleic acids as in vivo metabolite and ion biosensors
Alsaafin, A., & McKeague, M. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.02.030 · Cited by 42
Identification of serum protein biomarkers for utrophin based DMD therapy
Guiraud, S., Edwards, B., Squire, S. E., Babbs, A., Shah, N., Berg, A., Chen, H., & Davies, K. E. (2017) · Scientific Reports · doi:10.1038/srep43697 · Cited by 43
Cerebrospinal Fluid Protein Changes in Preeclampsia
Ciampa, E. J., Li, Y., Dillon, S. T., Lecarpentier, É., Sorabella, L. L., Libermann, T. A., Karumanchi, S. A., & Hess, P. E. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11153 · Cited by 40
Characterization of the plasma proteomic profile of frailty phenotype
Landino, K., Tanaka, T., Fantoni, G., Candia, J., Bandinelli, S., & Ferrucci, L. (2020) · GeroScience · doi:10.1007/s11357-020-00288-9 · Cited by 38
Advances in nucleic acid architectures for electrochemical sensing
Wu, Y., & Arroyo‐Currás, N. (2021) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2021.100695 · Cited by 40
Visvabharathy, L., Hanson, B. A., Orban, Z. S., Lim, P. H., Palacio, N. M., Jimenez, M., Clark, J. R., Graham, E. L., Liotta, E. M., Tachas, G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1155770 · Cited by 40
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
Pierson, S. K., Katz, L. M., Williams, R., Mumau, M. D., Gonzalez, M. V., Guzman, S., Rubenstein, A. I., Oromendia, A. B., Beineke, P., Fosså, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34873-7 · Cited by 40
In vitro selection of aptamers and their applications
DeRosa, M. C., Lin, A., Mallikaratchy, P. R., McConnell, E. M., McKeague, M., Patel, R. M., & Shigdar, S. L. (2023) · Nature Reviews Methods Primers · doi:10.1038/s43586-023-00247-6 · Cited by 83
Progress in Aptamer Research and Future Applications
Liu, S., Li, X., Gao, H., Chen, J., & Jiang, H. (2025) · ChemistryOpen · doi:10.1002/open.202400463 · Cited by 49
Aptamers and Their Significant Role in Cancer Therapy and Diagnosis
Prakash, J. J. S., & Rajamanickam, K. (2015) · Biomedicines · doi:10.3390/biomedicines3030248 · Cited by 36
DNA-assisted protein detection technologies
Nong, R. Y., Gu, J., Darmanis, S., Kamali‐Moghaddam, M., & Landegren, U. D. (2012) · Expert Review of Proteomics · doi:10.1586/epr.11.78 · Cited by 37
Sattlecker, M., Khondoker, M., Proitsi, P., Williams, S., Soininen, H., Kłoszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140669 · Cited by 36
Valenzano, S., Girolamo, A. D., DeRosa, M. C., McKeague, M., Schena, R., Catucci, L., & Pascale, M. (2016) · ACS Combinatorial Science · doi:10.1021/acscombsci.5b00163 · Cited by 41
Tsim, S., Kelly, C., Alexander, L. E. C., McCormick, C., THOMSON, F. J., Woodward, R., Foster, J. E., Stobo, D., Paul, J., Maskell, N. A., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013324 · Cited by 36
Duo, J., Chiriac, C., Huang, R. Y. ‐., Mehl, J. T., Chen, G., Tymiak, A. A., Sabbatini, P., Pillutla, R. C., & Zhang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05277 · Cited by 37
Hok‐A‐Hin, Y. S., Willemse, E. A. J., Teunissen, C. E., & del Campo, M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9706-0_2 · Cited by 39
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
Giudice, V., Mensitieri, F., Izzo, V., Filippelli, A., & Selleri, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093252 · Cited by 37
ANMerge: A Comprehensive and Accessible Alzheimer’s Disease Patient-Level Dataset
Birkenbihl, C., on behalf of the AddNeuroMed Consortium, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., & Hofmann-Apitius, M. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-200948 · Cited by 36
Population serum proteomics uncovers a prognostic protein classifier for metabolic syndrome
Cai, X., Xue, Z., Zeng, F., Tang, J., Yue, L., Wang, B., Ge, W., Xie, Y., Miao, Z., Gou, W., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101172 · Cited by 42
Aptamers: Promising Reagents in Biomedicine Application
Zhou, H., Li, Y., & Wu, W. (2024) · Advanced Biology · doi:10.1002/adbi.202300584 · Cited by 39
Detection of Clostridium difficile toxins A, B and binary toxin with slow off-rate modified aptamers
Ochsner, U. A., Katilius, E., & Janjić, N. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.03.029 · Cited by 35
Self-citationA Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin
Rice, L. M., Mantero, J. C., Stifano, G., Ziemek, J., Simms, R. W., Gordon, J., Domsic, R. T., & Lafyatis, R. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.027 · Cited by 34
Russell, T. M., Green, L. S., Rice, T., Kruh‐Garcia, N. A., Dobos, K. M., Groote, M. A. D., Hraha, T. H., Sterling, D. G., Janjić, N., & Ochsner, U. A. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00469-17 · Cited by 36
Self-citationDiagnostic and Therapeutic Value of Aptamers in Envenomation Cases
Ascoët, S., & WAARD, M. M. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103565 · Cited by 37
Pass, H. I., Alimi, M., Carbone, M., Yang, H., & Goparaju, C. M. V. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0083 · Cited by 39
Proteome-wide Systems Genetics to Identify Functional Regulators of Complex Traits
Molendijk, J., & Parker, B. L. (2021) · Cell Systems · doi:10.1016/j.cels.2020.10.005 · Cited by 37
Metabolic syndrome and the plasma proteome: from association to causation
Elhadad, M. A., Wilson, R., Zaghlool, S. B., Huth, C., Gieger, C., Grallert, H., Graumann, J., Rathmann, W., Köenig, W., Sinner, M. F., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01299-2 · Cited by 37
Wang, X., Chen, Z., Mishra, A. K., Silva, A., Ren, W., Pan, Z., & Wang, J. H. (2017) · Haematologica · doi:10.3324/haematol.2017.175992 · Cited by 36
Development of nucleic acid medicines based on chemical technology
Kawamoto, Y., Wu, Y., Takahashi, Y., & Takakura, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114872 · Cited by 34
Tsukita, K., Sakamaki‐Tsukita, H., Kaiser, S., Zhang, L., Messa, M., Serrano‐Fernández, P., & Takahashi, R. (2023) · Neurology · doi:10.1212/wnl.0000000000207725 · Cited by 44
Affinity‐based microarrays for proteomic analysis of cancer tissues
Hoheisel, J. D., Alhamdani, M. S. S., & Schröder, C. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200114 · Cited by 37
An overview of transducers as platform for the rapid detection of foodborne pathogens
Arora, P., Sindhu, A., Kaur, H., Dilbaghi, N., & Chaudhury, A. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4692-5 · Cited by 34
The use of multiplex platforms for absolute and relative protein quantification of clinical material
Christiansson, L., Mustjoki, S., Simonsson, B., Olsson-Strömberg, U., Loskog, A. S. I., & Mangsbo, S. M. (2014) · EuPA Open Proteomics · doi:10.1016/j.euprot.2014.02.002 · Cited by 34
Durand, G., Dausse, E., Goux, E., Fiore, E., Peyrin, É., Ravelet, C., & Toulmé, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw206 · Cited by 38
Aptamer Affinity Maturation by Resampling and Microarray Selection
Kinghorn, A. B., Dirkzwager, R. M., Liang, S., Cheung, Y., Fraser, L. A., Shiu, S. C., Tang, M. S. L., & Tanner, J. A. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01635 · Cited by 34
Shah, R. D., Xue, C., Zhang, H., Tuteja, S., Li, M., Reilly, M. P., & Ferguson, J. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169614 · Cited by 33
Fahrmann, J. F., Mao, X., Irajizad, E., Katayama, H., Capello, M., Tanaka, I., Kato, T., Wistuba, I. I., Maitra, A., Ostrin, E. J., et al. (2020) · Cancers · doi:10.3390/cancers12051147 · Cited by 41
Serum levels of ACE2 are higher in patients with obesity and diabetes
Emilsson, V., Gudmundsson, E. F., Aspelund, T., Jonsson, B. G., Guðjónsson, A., Launer, L. J., Lamb, J. R., Guðmundsdóttir, V., Jennings, L. L., & Gudnason, V. G. (2020) · Obesity Science & Practice · doi:10.1002/osp4.472 · Cited by 62
Hanff, T. C., Cohen, J. B., Zhao, L., Javaheri, A., Zamani, P. L., Prenner, S. B., Rietzschel, E. R., Jia, Y., Walsh, A. M., Maranville, J., et al. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.11.011 · Cited by 35
“Assay details have been previously described (15).”
Analytical Challenges in The Detection of Peptide Hormones For Anti-Doping Purposes
Barroso, O., Handelsman, D. J., Strasburger, C. J., & Thevis, M. (2012) · Bioanalysis · doi:10.4155/bio.12.128 · Cited by 34
Aptamer-based Theranostics in Oncology: Design Strategies and Limitations
Trivedi, J., Yasir, M., Maurya, R. K., & Tripathi, A. S. (2024) · BIO Integration · doi:10.15212/bioi-2024-0002 · Cited by 36
Advancing Small‐Molecule‐Based Chemical Biology with Next‐Generation Sequencing Technologies
Chandran, A., Kizaki, S., Bando, T., Pandian, G. N., & Sugiyama, H. (2014) · ChemBioChem · doi:10.1002/cbic.201402556 · Cited by 39
Rashid, M., Amiri, A. Z., Glover, K. K. M., Gao, A., Nickol, M. E., Kindrachuk, J., Wilkins, J. A., & Coombs, K. M. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008335 · Cited by 33
Yang, J. Y., Brody, E. N., Murthy, A. C., Mehler, R. E., Weiss, S. J., DeLisle, R. K., Ostroff, R. M., Williams, S. A., & Ganz, P. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016463 · Cited by 35
Self-citationType 2‐low asthma phenotypes by integration of sputum transcriptomics and serum proteomics
Kermani, N. Z., Saqi, M. A. S., Agapow, P., Pavlidis, S. P., Kuo, C. S., Tan, K. S., Mumby, S. E., Sun, K., Loza, M. J., Baribaud, F., et al. (2020) · Allergy · doi:10.1111/all.14573 · Cited by 35
Delivery of Nanoconstructs in Cancer Therapy: Challenges and Therapeutic Opportunities
Saw, W. S., Anasamy, T., Foo, Y. Y., Kwa, Y. C., Kue, C. S., Yeong, C. H., Kiew, L. V., Lee, H. B., & Chung, L. Y. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000206 · Cited by 35
Rethinking nucleic acids from their origins to their applications
Benner, S. A. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0027 · Cited by 36
Monteiro, J. P., Wise, C., Morine, M. J., Teitel, C. H., Pence, L. M., Williams, A., McCabe‐Sellers, B., Champagne, C. M., Turner, J., Shelby, B., et al. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0403-9 · Cited by 38
van Vugt, M., Finan, C., Chopade, S., Providencia, R. A., Bezzina, C. R., Asselbergs, F. W., van Setten, J., & Schmidt, A. F. (2024) · Genome Medicine · doi:10.1186/s13073-024-01395-4 · Cited by 40
AI-empowered perturbation proteomics for complex biological systems
Qian, L., Sun, R., Aebersold, R. H., Bühlmann, P., Sander, C., & Guo, T. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100691 · Cited by 37
The 2024 Report on the Human Proteome from the HUPO Human Proteome Project
Omenn, G. S., Orchard, S. E., Lane, L., Lindskog, C., Pineau, C., Overall, C. M., Budnik, B., Mudge, J. M., Packer, N. H., Weintraub, S. T., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00776 · Cited by 40
Epidemiologic Design and Analysis for Proteomic Studies: A Primer on -Omic Technologies
Mischak, H., Critselis, E., Hanash, S., Gallagher, W. M., Vlahou, A., & Ioannidis, J. P. A. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu462 · Cited by 35
Wilson, R., Bourne, C., Chaudhuri, R. R., Gregory, R., Kenny, J. G., & Cossins, A. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100572 · Cited by 32
Vandghanooni, S., Sanaat, Z., Farahzadi, R., Eskandani, M., Omidian, H., & Omidi, Y. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106640 · Cited by 35
Daniels, J. R., Ma, J. Z., Cao, Z., Beger, R. D., Sun, J., Schnackenberg, L. K., Pence, L. M., Choudhury, D., Palevsky, P. M., Portilla, D., et al. (2021) · Kidney360 · doi:10.34067/kid.0002642021 · Cited by 46
Petersen, T. B., de Bakker, M., Asselbergs, F. W., Harakaľová, M., Akkerhuis, K. M., Brugts, J. J., van Ramshorst, J., Lumbers, R. T., Ostroff, R. M., Katsikis, P. D., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104655 · Cited by 34
Self-citationProtein measurements in microwells
Walt, D. R. (2014) · Lab on a Chip · doi:10.1039/c4lc00277f · Cited by 36
Multiplexed Microcolumn-Based Process for Efficient Selection of RNA Aptamers
Latulippe, D. R., Szeto, K., Ozer, A., Duarte, F. M., Kelly, C. V., Pagano, J. M., White, B. S., Shalloway, D. I., Lis, J. T., & Craighead, H. G. (2013) · Analytical Chemistry · doi:10.1021/ac400105e · Cited by 36
Santos‐Parker, J. R., Santos-Parker, K. S., McQueen, M. B., Martens, C. R., & Seals, D. R. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00458.2018 · Cited by 33
Compensated Interferometry Measures of CYFRA 21–1 Improve Diagnosis of Lung Cancer
Kammer, M. N., Kussrow, A. K., Webster, R. L., Chen, H., Hoeksema, M., Christenson, R. H., Massion, P. P., & Bornhop, D. J. (2019) · ACS Combinatorial Science · doi:10.1021/acscombsci.9b00022 · Cited by 34
Application of Proteomics Profiling for Biomarker Discovery in Hypertrophic Cardiomyopathy
Shimada, Y. J., Hasegawa, K., Kochav, S. M., Mohajer, P., Jung, J., Maurer, M. S., Reilly, M. P., & Fifer, M. A. (2019) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-019-09896-z · Cited by 33
Multimodal immune phenotyping of maternal peripheral blood in normal human pregnancy
Apps, R., Kotliarov, Y., Cheung, F., Han, K. L., Chen, J., Biancotto, A., Babyak, A. L., Zhou, H., Shi, R., Barnhart, L. A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134838 · Cited by 32
CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers
Ahmad, S., Milan, M. D. C., Hansson, O., Demirkan, A., Agustin, R., Sáez, M. E., Giagtzoglou, N., Cabrera-Socorro, A., Bakker, M. H. M., Ramirez, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65038-5 · Cited by 31
“The levels of CSF AD-related biomarkers (Aβ42, total and phosphorylated tau [t-Tau and p-Tau181]) were analyzed at Amsterdam UMC as part of the routine diagnostic procedure using commercially available kits (Innotest Aβ(1-42), total Tau, phospho-Tau(181 P); Fujirebio, Ghent, Belgium)10,24.”
MethodIntegrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
Valsesia, A., Chakrabarti, A., Hager, J., Langin, D., Saris, W. H. M., Astrup, A. V., Blaak, E. E., Viguerie, N., & Masoodi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65936-8 · Cited by 31
Integrated OMICs unveil the bone-marrow microenvironment in human leukemia
Passaro, D., Albornoz, M. G., Diana, G., Chakravarty, P., Ariza‐McNaughton, L., Batsivari, A., Borràs-Eroles, C., Abarrategi, A., Waclawiczek, A., Ombrato, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109119 · Cited by 33
Use of Silicon Nanowire Sensors for Early Cancer Diagnosis
Ivanov, Y. D., Romanova, T. S., Malsagova, K. A., Pleshakova, T. O., & Archakov, A. I. (2021) · Molecules · doi:10.3390/molecules26123734 · Cited by 31
Bhatti, G., Romero, R. J., Gomez‐Lopez, N., Chaiworapongsa, T., Jung, E., Gotsch, F., Piqué-Regi, R., Pacora, P., Hsu, C., Kavdia, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04050-9 · Cited by 32
Protein prediction for trait mapping in diverse populations
Schubert, R., Geoffroy, E., Gregga, I., Mulford, A. J., Aguet, F., Ardlie, K., Gerszten, R. E., Clish, C. B., Berg, D. V. D., Taylor, K. D., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264341 · Cited by 28
Cederberg, K. L. J., Hanif, U., Sempere, V. P., Hedou, J. J., Leary, E. B., Schneider, L. D., Lin, L., Zhang, J., Morse, A. M., Blackman, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147983 · Cited by 34
Aptamers as Theragnostic Tools in Prostate Cancer
Cruz-Hernández, C. D., Martinez, G. R., Cortés-Ramírez, S. A., Morales-Pacheco, M., Cruz-Burgos, M., Losada-García, A., Reyes‐Grajeda, J. P., González-Ramírez, I., González-Covarrubias, V., Camacho‐Arroyo, I., et al. (2022) · Biomolecules · doi:10.3390/biom12081056 · Cited by 39
In vitro evolution of ribonucleases from expanded genetic alphabets
Jerome, C. A., Hoshika, S., Bradley, K. M., Benner, S. A., & Biondi, E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208261119 · Cited by 34
Enhanced Multiplexing Technology for Proteomics
Bowser, B. L., & Robinson, R. A. S. (2023) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-091622-092353 · Cited by 34
Pharmacokinetic Properties of DNA Aptamers with Base Modifications
Gupta, S., Drolet, D. W., Wolk, S. K., Waugh, S. M., Rohloff, J. C., Carter, J. D., Mayfield, W. S., Otis, M. R., Fowler, C. R., Suzuki, T. W., et al. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0683 · Cited by 36
Self-citationJalili, R., Horecka, J., Swartz, J. R., Davis, R. W., & Persson, H. H. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718283115 · Cited by 34
Particle Display: A Quantitative Screening Method for Generating High‐Affinity Aptamers
Wang, J., Gong, Q., Maheshwari, N., Eisenstein, M. S., Arcila, M. L., Kosik, K. S., & Soh, H. T. (2014) · Angewandte Chemie · doi:10.1002/ange.201309334 · Cited by 33
Du, S., Chen, J., Kim, H., Walker, M. E., Lichtenstein, A. H., Chatterjee, N., Ganz, P., Yu, B., Vasan, R. S., Coresh, J., et al. (2022) · Journal of Nutrition · doi:10.1016/j.tjnut.2022.11.008 · Cited by 33
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.